Stories
Slash Boxes
Comments

SoylentNews is people

SoylentNews is powered by your submissions, so send in your scoop. Only 17 submissions in the queue.
posted by martyb on Sunday April 09 2017, @12:55AM   Printer-friendly
from the to-look-or-not-to-look dept.

https://mobile.nytimes.com/2017/04/06/health/fda-genetic-tests-23andme.html

For the first time, the Food and Drug Administration said it would allow a company to sell genetic tests for disease risk directly to consumers, providing people with information about the likelihood that they could develop various conditions, including Parkinson's and Alzheimer's.

The move on Thursday is a turnaround for the agency, which had imposed a moratorium in 2013 on disease tests sold by the company, 23andMe, which is based in Mountain View, Calif. The decision is expected to open the floodgates for more direct-to-consumer tests for disease risks, drawing a road map for other companies to do the same thing.

If you could take such a test, would you? Or would you rather just take things as they come?


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 2) by Anne Nonymous on Sunday April 09 2017, @02:16PM

    by Anne Nonymous (712) on Sunday April 09 2017, @02:16PM (#491168)

    23andme is the Name-A-Star of genetic testing.

    Starting Score:    1  point
    Karma-Bonus Modifier   +1  

    Total Score:   2